Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
COMPANY
ACF Equity Research
Accuracy | Clarity | Foresight
Follow
Location:
United Kingdom
61
Insights
26.5k
Views
3
Followers
Equities
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
Merus NV
•
29 Apr 2025 15:00
•
Issuer-paid
Merus NV - ACF Thematic Oncology Lung Cancer Cough LCC 25042025
Lung Cancer Cough (LCC) is an under-served, perhaps unserved therapeutic subsegment of the Lung Cancer/Oncology market. 57-65% of early diagnosis...
ACF Equity Research
Follow
23 Views
Share
bullish
•
BrainStorm Cell Therapeutics I
•
09 Apr 2025 21:00
•
Issuer-paid
BrainStorm Cell Therapeutics (BCLI) - Fundamentals Update 09042025
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou...
ACF Equity Research
Follow
226 Views
Share
bullish
•
Thematic (Sector/Industry)
•
14 Mar 2025 00:29
•
Issuer-paid
ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025
Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge.
ACF Equity Research
Follow
166 Views
Share
bullish
•
AsiaFIN Holdings
•
13 Mar 2025 23:13
•
Issuer-paid
AsiaFIN Holdings Corp (ASFH) Pre-Results 4Q24 12032025
AsiaFIN Holdings Corp. (OTCQB : ASFH) – provides IP protected fintech solutions to ASEAN (excluding China & India) based financial institutions /...
ACF Equity Research
Follow
159 Views
Share
bullish
•
NLS Pharmaceutics
•
14 Feb 2025 02:40
•
Issuer-paid
NLS Pharmaceutics (NLSP) Core Investment Case 13022025
NLS Pharmaceutics (NLSP:NasdaqCM) is a clinical-stage Swiss foreign issuer biotech advancing the Dual Orexin Receptor Agonist (DOXA) platform
ACF Equity Research
Follow
144 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.1
x